Clinisys acquires Orchard Software
BANGALORE, India and TUCSON, Ariz., Aug. 1, 2025 /PRNewswire/ -- Clinisys today announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys's continued commitment to provide the laboratory informatics marketplace with cutting-edge software advancements. The combined capabilities provide for comprehensive, flexible and scalable informatics offerings that can better serve customers across the global diagnostics market.
"Joining forces with Clinisys marks a powerful new chapter for Orchard," said Billie Whitehurst, Orchard's CEO. "Our mission has always been to equip laboratorians with the tools they need to provide high-quality, efficient care. Clinisys shares that commitment and brings the global scale and innovation expertise needed to advance that mission even further."
"We are excited to welcome Orchard to the Clinisys family," said Michael Simpson, Clinisys's CEO. "As a global leader in lab informatics, with over 45 years of domain experience, Clinisys has a clear strategy to create and deliver the next evolution of cloud‑based laboratory solutions. As we continue to pursue excellence in developing both our world class solutions and our industry expertise, expanding with Orchard's proven solution in the physician-office, reference, and veterinary laboratory space was a clear decision for us. Together, we can better serve the entire spectrum of lab and diagnostic customers by enabling healthier and safer communities worldwide."
Francisco Partners acquired Orchard Software in 2019, and since investing in the company the firm has implemented a strategic transformation of the business, including modernizing Orchard's product suite, enhancing its cloud solutions and strengthening its leadership team.
"We are incredibly proud to have partnered with Orchard and supported its growth story over the past few years," said Anders Mikkelsen, Principal at Francisco Partners. "We would like to thank Billie and the Orchard management team for their outstanding work to position the company for long-term success. Clinisys and Roper Technologies are the ideal strategic partners to support Orchard's next growth chapter, and we look forward to seeing the company continue to thrive."
The combination of Orchard's LIS portfolio and Clinisys's LIMS and diagnostic solutions creates new opportunities for customers across North America and international markets.
Aeris Partners served as the exclusive financial advisor, and Kirkland & Ellis LLP served as the legal advisor to Francisco Partners and Orchard Software.
About Clinisys
Clinisys is a global provider of intelligent laboratory informatics solutions that support a healthier and safer world. Serving healthcare, life sciences, and public health customers, Clinisys is headquartered in Tucson, Arizona; Raleigh, NC; Woking, England; and Ghent, Belgium. Millions of laboratory results and data insights are generated every day using Clinisys's platform and cloud-based solutions in over 4,000 laboratories across 39 countries. Learn more at www.clinisys.com.
About Orchard Software
Founded in 1993, Orchard Software is a pioneer in laboratory information systems designed to meet the needs of diverse clinical settings. Orchard's award-winning products are used by more than 2,000 laboratories across the United States in physician groups, hospitals, reference labs, student health centers, veterinary clinics, and public health organizations. Learn more at www.orchardsoft.com.
About Francisco Partners
Francisco Partners is a leading global investment firm that specializes in partnering with technology and technology-enabled businesses. Since its launch over 25 years ago, Francisco Partners has invested in more than 450 technology companies, making it one of the most active and outstanding investors in the technology industry. With more than $50 billion in capital raised, the firm invests in opportunities where its deep sectoral knowledge and operational expertise can help companies realize their full potential. For more information on Francisco Partners, please visit www.franciscopartners.com.
Media Contact:Clinisys Contact: Michele SchicchiGlobal VP, Marketing and Corporate Communications, CMOClinisys520.570.2552Michele.Schicchi@clinisys.com
Francisco Partners:Prosek Partners for Francisco PartnersPro-FP@prosek.com
Logo: https://mma.prnewswire.com/media/2598775/5117656/Clinisys_Logo.jpg
View original content:https://www.prnewswire.com/in/news-releases/clinisys-acquires-orchard-software-302519457.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Virtual Flip Formula Launches Rebranded Mentorship Program for New Real Estate Wholesalers
Phoenix, Arizona--(Newsfile Corp. - August 17, 2025) - Virtual Flip Formula, a real estate education company founded by Tyson Smith, has announced the formal launch and rebranding of its mentorship-based training program for aspiring real estate wholesalers. Based in Phoenix, Arizona, the company provides remote coaching and support designed for individuals seeking to break into the real estate industry without the need to purchase or own property. To view an enhanced version of this graphic, please visit: A Streamlined Approach to Entry-Level Real Estate Business Models Virtual Flip Formula focuses on real estate wholesaling - a model where individuals earn fees by connecting property sellers with buyers. This approach allows participants to operate without purchasing real estate themselves, which makes the model accessible to those without substantial upfront capital. Rather than relying on traditional real estate investment strategies that require financing or ownership, Virtual Flip Formula provides an alternative route that emphasizes hustle, outreach, and structured negotiation. From Informal Demand to Structured Support The concept originated after founder Tyson Smith began receiving requests from his social media audience to share how he had built his wholesaling business. What began as informal guidance grew into a structured program featuring weekly coaching calls, digital tools, and peer support. "Once I saw the kind of life-changing results people were getting after learning the process, I knew there was an opportunity to build something more formal and supportive," said Tyson Smith, CEO of Virtual Flip Formula. The company initially launched in 2023 but underwent a rebrand and operational refinement in early 2025 to better align with the needs of its growing student base. To view an enhanced version of this graphic, please visit: Program Designed for Accessibility and Sustainability The mentorship program includes weekly coaching sessions, operational frameworks, and guided exercises aimed at helping new wholesalers close their first deal. According to the company, the core objective is to take students from zero experience to generating consistent income through repeatable systems. "What sets our model apart is the focus on accessibility," said Smith. "Most beginners don't have tens of thousands in capital to purchase real estate. With wholesaling, you don't need to. What you need is structure, support, and the discipline to take action." Building a Supportive Community of First-Time Wholesalers Looking ahead, Virtual Flip Formula plans to support over 1000 new wholesalers in closing their first deal within the next 12 to 24 months. Long-term, the company aspires to build a national community where students can share resources, partner on deals, and create business momentum together. "We're creating an environment where students aren't just learning from us - they're learning from each other," Smith noted. "It's about building something that lasts beyond one course or one deal." About Virtual Flip Formula Virtual Flip Formula is a mentorship-based program designed to help beginners launch real estate wholesaling businesses. The company operates remotely and provides coaching, strategy, and support for aspiring entrepreneurs seeking a practical entry point into the real estate industry. For more information, visit: To follow Tyson Smith's work, connect with him on Instagram or YouTube. Media Contact Company Name: Virtual Flip FormulaContact Name: Tyson SmithCountry: Phoenix, AZ, USAEmail: team@ SOURCE: Virtual Flip Formula To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
42 minutes ago
- Yahoo
Great week for The Hain Celestial Group, Inc. (NASDAQ:HAIN) institutional investors after losing 72% over the previous year
Key Insights Given the large stake in the stock by institutions, Hain Celestial Group's stock price might be vulnerable to their trading decisions A total of 14 investors have a majority stake in the company with 52% ownership Recent purchases by insiders AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. A look at the shareholders of The Hain Celestial Group, Inc. (NASDAQ:HAIN) can tell us which group is most powerful. The group holding the most number of shares in the company, around 80% to be precise, is institutions. In other words, the group stands to gain the most (or lose the most) from their investment into the company. After a year of 72% losses, last week's 13% gain would be welcomed by institutional investors as a possible sign that returns might start trending higher. Let's take a closer look to see what the different types of shareholders can tell us about Hain Celestial Group. See our latest analysis for Hain Celestial Group What Does The Institutional Ownership Tell Us About Hain Celestial Group? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Hain Celestial Group already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Hain Celestial Group's historic earnings and revenue below, but keep in mind there's always more to the story. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. Hedge funds don't have many shares in Hain Celestial Group. BlackRock, Inc. is currently the company's largest shareholder with 7.4% of shares outstanding. The Vanguard Group, Inc. is the second largest shareholder owning 7.2% of common stock, and PGGM holds about 4.6% of the company stock. Looking at the shareholder registry, we can see that 52% of the ownership is controlled by the top 14 shareholders, meaning that no single shareholder has a majority interest in the ownership. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. Insider Ownership Of Hain Celestial Group While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances. Our most recent data indicates that insiders own some shares in The Hain Celestial Group, Inc.. In their own names, insiders own US$2.8m worth of stock in the US$167m company. Some would say this shows alignment of interests between shareholders and the board, though we generally prefer to see bigger insider holdings. But it might be worth checking if those insiders have been selling. General Public Ownership The general public, who are usually individual investors, hold a 19% stake in Hain Celestial Group. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. Next Steps: It's always worth thinking about the different groups who own shares in a company. But to understand Hain Celestial Group better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Hain Celestial Group you should know about. If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Trump administration tiptoes into testing prior authorization in traditional Medicare
Traditional Medicare plan holders have typically not had to wait for prior authorization before receiving medical treatment. Until now. The Centers for Medicare & Medicaid Services (CMS) recently announced a new program to test prior authorization requirements for certain services in six states starting Jan. 1. The states — New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington — will apply prior authorization evaluations to more than a dozen services. CMS says the pilot program is intended to root out 'fraud, waste, and abuse,' but as Medicare Advantage members know well, prior authorization can lead to frustrating delays in care. How it works CMS will contract with private companies to deploy 'enhanced technologies, including artificial intelligence (AI)' to conduct the authorization reviews. It won't apply to in-patient or emergency services or treatments 'that would pose a substantial risk to patients if significantly delayed,' according to a CMS press release. Specific services that will require prior authorization are skin and tissue substitutes, electrical nerve stimulator implants, and knee arthroscopy. There is genuine concern about the costs of some of these items and services. A recent New York Times article highlighted pricey medical products, including paper-thin bandages made of dried bits of placenta, for Medicare patients. The Biden administration had approved a plan to limit Medicare's coverage of the bandages, known as skin substitutes, which were reportedly being sold for roughly $10,000 per square inch. An updated Medicare policy proposes setting a significantly lower payment rate. The new prior authorization program 'is focused on reducing wasteful spending, which is an important goal for Medicare,' Jeffrey Marr, a health economist at the Brown University School of Public Health, told Yahoo Finance. 'I expect that the use of prior authorization in this model is likely to reduce the overall level of Medicare spending,' he said. 'Selecting potentially low-value services is a critical part of setting up a well-functioning prior authorization system.' The key question for CMS to address is whether prior authorization can work in traditional Medicare in a way that does not deny or discourage high-value care that improves beneficiaries' health, Marr said. One red flag: 'The companies that will make the prior authorization decisions will be paid a percentage of the savings that they generate for Medicare. This creates an incentive for participants to deny a high share of services,' he said. Sign up for the Mind Your Money weekly newsletter By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy Prior authorizations are part of the Medicare landscape How often do prior authorizations pop up for seniors with Medicare and Medicare Advantage plans? In traditional Medicare, services that often require prior authorization include certain outpatient hospital services, non-emergency ambulance transport, and durable medical equipment. For 2023, under 400,000 prior authorization reviews for traditional Medicare beneficiaries were submitted to CMS, according to KFF data. Medicare Advantage plans, which are offered by private insurers, are a different story. Almost all Medicare Advantage enrollees — 99% according to KFF research — must receive prior authorization for some services. These are typically higher-cost services, such as inpatient hospital stays, skilled nursing facility stays, chemotherapy, and other drugs. That common practice, combined with AI used to scan these requests, is a thorny issue. 'Prior authorization processes and requirements, including the use of artificial intelligence to review requests, may result in administrative hassles for providers, delays for patients in receiving necessary care, and in some instances, denials of medically necessary services, such as post-acute care,' according to Jeannie Fuglesten Biniek, co-author of the KFF report. To allay that fear, CMS noted in the announcement: 'While technology will support the review process, final decisions that a request for one of the selected services does not meet Medicare coverage requirements will be made by licensed clinicians, not machines.' The prior authorization program will not alter Medicare coverage or payment rules, for now, but other services may be added later. There has been pushback. More than a dozen members of Congress sent a letter on Aug. 7 to CMS administrator Dr. Memet Oz to urge him to 'put patients and providers first by cancelling' the model and requested more details about how the program will be implemented. 'The use of prior authorization in Medicare Advantage shows us that, in practice, [this proposal] will likely limit beneficiaries' access to care, increase burden on our already overburdened healthcare workforce, and create perverse incentives to put profit over patients,' the lawmakers wrote.A pivot in MA authorization In an odd juxtaposition, a week prior to trumpeting this new Medicare pre-authorization model, the administration announced that it had a non-binding commitment from insurance plans to reduce prior authorization in Medicare Advantage. In late June, the Department of Health and Human Services announced an initiative coordinated with companies including Aetna, Blue Cross Blue Shield, Humana, and UnitedHealthcare, to streamline prior authorization processes for patients covered by Medicare Advantage. Under the initiative, electronic prior authorization requests would become standardized by 2027. 'Pitting patients and their doctors against massive companies was not good for anyone,' US Health and Human Services Secretary Robert F. Kennedy, Jr. said in a statement. 'We are actively working with industry to make it easier to get prior authorization for common services such as diagnostic imaging, physical therapy, and outpatient surgery.' Oz added: 'These commitments represent a step in the right direction toward restoring trust, easing burdens on providers, and helping patients receive timely, evidence-based care.' Kerry Hannon is a Senior Columnist at Yahoo Finance. She is a career and retirement strategist and the author of 14 books, including the forthcoming "Retirement Bites: A Gen X Guide to Securing Your Financial Future," "In Control at 50+: How to Succeed in the New World of Work," and "Never Too Old to Get Rich." Follow her on Bluesky. Sign up for the Mind Your Money newsletter
